World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03450499
Date of registration: 18/02/2018
Prospective Registration: Yes
Primary sponsor: B.P. Koirala Institute of Health Sciences
Public title: Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section
Scientific title: Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section
Date of first enrolment: April 1, 2018
Target sample size: 80
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03450499
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).  
Phase:  Phase 4
Countries of recruitment
Nepal
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- • All women at term(>or =37 weeks of gestation)

- Healthy

- American Society of Anesthesiologists(ASA) class1 and 2

- Women undergoing non-elective caesarean section whose anesthetic plan is for
spinal anesthesia with bupivacaine and fentanyl

Exclusion Criteria:

- • Women with American society of anesthesiologist physical status>2

- Body mass index >or =40 kg per square meter

- Height <150 cm

- Any contraindication to the spinal anesthesia

- History of substance abuse

- History of hallucinations

- Chronic opioid therapy

- Chronic pain or on any pain medication currently

- Patient with maternal complications,like cardiovascular disease
pre-eclampsia,diabetes,multiple gestation,known fetal abnormality

- Cases with severely compromised fetus where immediate administration of general
anesthesia is required.



Age minimum: 18 Years
Age maximum: 35 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Non Elective Cesarean Section and Ketamine Analgesia
Intervention(s)
Drug: Ketamine
Drug: Placebo
Primary Outcome(s)
Total opioid requirement postoperatively [Time Frame: 24 hrs]
Secondary Outcome(s)
Time to first perception of pain [Time Frame: 24 hrs]
Postoperative numerator rating scores(NRS)up to 24 hrs . postoperative ) [Time Frame: 24 hrs]
Incidence of side effects [Time Frame: 24 hrs]
Secondary ID(s)
IRC/1089/017
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history